Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and research reagents, is pleased to announce that the Group’s Chief Executive, Alastair Smith, will be presenting at the Proactive Investors One2One Investor Forum on the 5 April 2018 at the Chesterfield Mayfair Hotel, 35 Charles Street, Mayfair, W1J 5EB.
The evening event, which begins at 6pm , provides an opportunity for investors to hear about the opportunity for the Group’s Affimer technology, its development plans and to discuss these with Alastair.